← Leaderboards
Ioannis Zervantonakis
Harvard Medical School
$2,163,325
Attributed
$2,163,325
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $391.6K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,163,325 · 3
By mechanism
R35$1,169,785 · 1
R00$740,950 · 1
K99$252,590 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Allon Moshe Klein$7,807,178
- Suzanne L. Walker$40,048,648
- Arlene H Sharpe$68,359,602
- Radhika Mathur$229,184
- Daniel E Wagner$3,222,887
Others in their field
Other Emerging Leaders on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$91,415,673
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
Research focus
InsightEnvironmentResponseBiomedical EngineeringCommunicationCell CommunicationFibroblastsMicrofluidicsSignal TransductionCell TypeCellsCareer DevelopmentBreast Cancer Cell LineCancer TherapyCancer ImagingApoptosisComputer ModelsCancer BiologyCell SurvivalData SetClinical TrialsCombination Drug TherapyCombined Modality TherapyCell Stroma
Grant awards (8)
Macrophage-Fibroblast Communication in Cell Migration and Extracellular Matrix Remodeling$389,240
R35 · FY2025 · GM · contact PI
Macrophage-Fibroblast Communication in Cell Migration and Extracellular Matrix Remodeling$388,945
R35 · FY2024 · GM · contact PI
Macrophage-Fibroblast Communication in Cell Migration and Extracellular Matrix Remodeling$391,600
R35 · FY2023 · GM · contact PI
Analysis of tumor-stroma signaling that mediates HER2-therapy resistance in breast cancer$232,845
R00 · FY2021 · CA · contact PI
Analysis of tumor-stroma signaling that mediates HER2-therapy resistance in breast cancer$248,999
R00 · FY2020 · CA · contact PI
Analysis of tumor-stroma signaling that mediates HER2-therapy resistance in breast cancer$259,106
R00 · FY2019 · CA · contact PI
Analysis of tumor-stroma signaling that mediates HER2-therapy resistance in breast cancer$126,295
K99 · FY2018 · CA · contact PI
Analysis of tumor-stroma signaling that mediates HER2-therapy resistance in breast cancer$126,295
K99 · FY2017 · CA · contact PI